Patient-Friendly Explanation

Bariatric embolization is an experimental, minimally invasive procedure in which tiny particles are injected to reduce blood flow to the part of the stomach that produces the hunger hormone ghrelin, with the aim of reducing appetite. It is performed through a small tube in the groin without surgery, but it is not yet a standard treatment.

Clinical Definition

Bariatric (left gastric artery) embolization is an investigational interventional radiology procedure in which the arteries supplying the gastric fundus are selectively embolised to reduce ghrelin-producing cells. Early trials suggest modest weight loss through appetite suppression with a favourable safety profile compared to bariatric surgery, but larger randomised trials are needed before it can be recommended for routine clinical use.

Why It Matters

Minimally invasive options such as bariatric embolization may one day offer a middle ground between medication and surgery for obesity. NuLifeCare Singapore monitors these developments so patients receive accurate, up-to-date guidance on all available treatment pathways.